Element Capital Management LLC Enanta Pharmaceuticals Inc Transaction History

Element Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$81.3 - $97.35 $337,638 - $404,294	-4,153 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$69.08 - $105.66 $13,954 - $21,343	202 Added 5.11%	4,153 $397,000
Q4 2018 Feb 13, 2019	SELL	$65.41 - $84.65 $225,010 - $291,196	-3,440 Reduced 46.54%	3,951 $280,000
Q3 2018 Nov 14, 2018	BUY	$85.46 - $126.37 $262,362 - $387,955	3,070 Added 71.05%	7,391 $632,000
Q2 2018 Aug 14, 2018	BUY	$81.85 - $120.51 $12,113 - $17,835	148 Added 3.55%	4,321 $501,000
Q1 2018 May 15, 2018	BUY	$57.91 - $92.15 $241,658 - $384,541	4,173 New	4,173 $338,000

108

21.1M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $109M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Element Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Element Capital Management LLC with notifications on news.